• Metformin HCl: Reliable Assay Workflows

  2026-09-22

  A scenario-based guide to using Metformin Hydrochloride (Metformin HCl), SKU B1970, in viability, proliferation, cytotoxicity, and immunometabolic assays. It connects mechanism, formulation, protocol controls, and data interpretation to improve reproducibility without overstating what a metabolic readout proves.

• SM-102 for mRNA Delivery: Evidence and Workflow

  2026-09-22

  SM-102 is an ionizable lipid component used in lipid nanoparticles for mRNA delivery and mRNA vaccine development. Product specifications support a molecular weight of 710.18 g/mol, 98.00% purity, ethanol solubility of at least 175.8 mg/mL, and storage at −20 °C or below, while current peer-reviewed evidence should not be interpreted as a direct SM-102 performance benchmark.

• Metformin HCl: From AMPK Biology to Fibrosis Strategy

  2026-09-21

  A translational perspective on how Metformin Hydrochloride connects metabolic control with AMPK-centered antifibrotic research, using vocal fold fibrosis as a model for mechanism-led experimental design.

• IPR-803 and uPAR–uPA Inhibition in Metastasis

  2026-09-21

  The reference study advanced compound 4, identified here as IPR-803, from a computationally discovered uPAR–uPA interaction hit to a chemically synthesized and biologically validated inhibitor. Orthogonal binding assays, breast cancer invasion experiments, pharmacokinetic analysis, and a mouse metastasis model connected direct uPAR engagement with reduced extracellular-matrix degradation and lung metastatic burden.

• ICAA Targets RIP3 in Ang II Cardiac Hypertrophy

  2026-09-20

  The reference study identifies isochlorogenic acid A as a direct regulator of RIP3 in angiotensin II- and pressure overload-associated cardiac hypertrophy. Its data connect RIP3 to CaMKII activation independently of MLKL, suggesting a mechanistically distinct target for cardiovascular disease research while highlighting important preclinical limitations.

• SB743921: KSP Inhibitor Workflow for Cancer Research

  2026-09-19

  Build more informative mitotic-arrest assays with SB743921 by separating growth inhibition from actual cell killing. This workflow combines concentration and time-course optimization, orthogonal readouts, and troubleshooting guidance for cancer cell lines and tumor xenograft models.

• Premature Stimulation Expands Atrial Slow Conduction

  2026-09-19

  Lange and colleagues show that premature stimulation enlarges pre-existing slow-conduction regions in persistent atrial fibrillation rather than primarily creating new regions. Their optical-mapping framework links pacing history and propagation direction to dynamic atrial conduction heterogeneity, offering a useful model for studying arrhythmogenic substrate and therapeutic response.

• Sodium salicylate NF-κB assay workflow

  2026-09-18

  Build reproducible inflammation, oxidative stress, and stromal-signaling assays with Sodium salicylate as a soluble NF-κB inhibitor. The workflow also shows how this small-molecule comparator can complement, but not replace, the sequential stromal-remodeling strategy reported for pancreatic cancer nanomedicine.

• AY 9944 Dihydrochloride: DHCR7 Evidence

  2026-09-17

  AY 9944 dihydrochloride is a selective DHCR7 inhibitor for controlled sterol-perturbation experiments. Product data report a 13 nM IC50 against recombinant human DHCR7, while recent dhcr7 knockout evidence links pathway disruption to stronger antiviral immunity in grass carp.

• TRIM66 and Monogenic Olfactory Receptor Choice

  2026-09-17

  The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence surplus olfactory receptor genes and preserve monogenic receptor expression. Its deletion disrupts receptor-expression precision, olfactory information processing, and innate behavior, linking enhancer repression to sensory function.

• GSDMC Drives PDAC Stemness and Immune Evasion

  2026-09-16

  A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a transcriptional regulator of pancreatic ductal adenocarcinoma progression rather than only a pyroptosis-associated pore-forming protein. The work connects ADAM17-dependent cleavage, nuclear GSDMC fragments, CXCL9-mediated immune remodeling, and improved responses to KRASG12D inhibition and PD-1 blockade.

• JZL184 Workflow for Endocannabinoid Pain Research

  2026-09-16

  JZL184 provides a direct way to increase 2-arachidonoylglycerol while separating MAGL biology from broader cannabinoid pharmacology. This workflow connects lipid measurements, CB1-dependent synaptic assays, and sensory-affective pain phenotyping for more interpretable neuropharmacology studies.

• Sulfo-Cy3 Azide for Translational Neurobiology

  2026-09-15

  Sulfo-Cy3 azide connects aqueous Click Chemistry fluorescent labeling with the growing need for spatially resolved neurodevelopmental assays. This article explains the mechanistic rationale, interprets the Nurr1 neurogenetic findings of Fang et al., and offers a practical framework for translating alkyne-enabled labeling into more reproducible microscopy workflows.

• ω-Agatoxin IVA in Cortical Excitotoxicity

  2026-09-15

  The 1996 reference study tested whether selective blockade of P- and Q-type calcium channels could reduce excitotoxic injury in neuron-enriched cortical cultures. ω-Agatoxin IVA did not decrease LDH-defined toxicity caused by veratridine, ouabain, or NMDA at concentrations below 300 nM, highlighting the difference between inhibiting neurotransmitter release and producing neuroprotection.

• Metformin Hydrochloride in Fibrosis Workflows

  2026-09-14

  Metformin Hydrochloride connects metabolic intervention with fibrosis biology through a practical AMPK-centered workflow. This guide translates a vocal-fold injury study into cell-based, tissue-level, and troubleshooting strategies while keeping dose, solvent, and mechanism controls explicit.

7920 records 1/528 page Next 12345 下5页 Last page